Articles Posted October 2012

  • Auscultation

    [gview file=””]

  • Amgen’s Anemia Drugs Aranesp and Epogen

      Amgen is accused in overfilling anemia  medicine Aranesp so that doctors could give the “free”medicines to patients and then bill insurance companies for it. In this case, drug makers worked hard to make sure that doctors give large doses so that the incentive was large. They offered discounts if the drug was used in large big volumes. […]

  • Diet, Exercise May Boost ‘Good’ Cholesterol, Study Suggests

    Benefits of lifestyle changes go beyond weight loss for diabetes patients, researcher says. For overweight people with diabetes, intensive exercise and dieting not only aids weight loss, it can also help train their fat cells to produce a hormone believed to boost production of “good” cholesterol, according to a new study. And this so-called “good” […]

  • Diabetes Screening Study Finds No Reduction In Mortality Rates

    Screening for type 2 diabetes does not appear to affect overall population mortality rates, according to a new study published in The Lancet.               The randomised trial, which is the first ever study evaluating the effect of type 2 diabetes screening programmes on overall mortality rates in a population, assessed the […]

  • Abbott Labs fined $1.5 Billion as penalty for Off-label Promotion of Depakote

    Global Health Care Company Abbott Laboratories Inc. pleaded guilty and agreed to pay $1.5 billion to resolve  its criminal and civil liability arising from the company’s unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration (FDA). The FDA is responsible for approving drugs […]